DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,707,425 | +15.6% | 6,882 | +11.8% | 0.06% | +20.8% |
| Q2 2023 | $1,477,440 | -53.6% | 6,156 | -51.3% | 0.05% | -55.6% |
| Q1 2023 | $3,182,761 | +107900.0% | 12,628 | +13.7% | 0.11% | +1.9% |
| Q4 2022 | $2,947 | -99.9% | 11,103 | +7.5% | 0.11% | +1.9% |
| Q3 2022 | $2,667,000 | -3.7% | 10,324 | -5.5% | 0.10% | +4.0% |
| Q2 2022 | $2,769,000 | -13.4% | 10,922 | +0.2% | 0.10% | +1.0% |
| Q1 2022 | $3,197,000 | -20.7% | 10,899 | -11.1% | 0.10% | -16.8% |
| Q4 2021 | $4,033,000 | +6.6% | 12,259 | -1.4% | 0.12% | -23.2% |
| Q3 2021 | $3,785,000 | +8.7% | 12,431 | -4.2% | 0.16% | +7.6% |
| Q2 2021 | $3,483,000 | -9.3% | 12,978 | -23.9% | 0.14% | -13.3% |
| Q1 2021 | $3,841,000 | +16.4% | 17,063 | +14.9% | 0.17% | +9.9% |
| Q4 2020 | $3,299,000 | -2.7% | 14,850 | -5.7% | 0.15% | -13.2% |
| Q3 2020 | $3,392,000 | +5.9% | 15,754 | -13.0% | 0.17% | +3.0% |
| Q2 2020 | $3,203,000 | +7.3% | 18,115 | -16.0% | 0.17% | -6.6% |
| Q1 2020 | $2,986,000 | +97.1% | 21,573 | +118.5% | 0.18% | +147.9% |
| Q4 2019 | $1,515,000 | +6.7% | 9,871 | +0.4% | 0.07% | 0.0% |
| Q3 2019 | $1,420,000 | +33.5% | 9,836 | +32.1% | 0.07% | +28.1% |
| Q2 2019 | $1,064,000 | +227.4% | 7,446 | +202.9% | 0.06% | +235.3% |
| Q1 2019 | $325,000 | +7.3% | 2,458 | -16.2% | 0.02% | -5.6% |
| Q4 2018 | $303,000 | -79.2% | 2,933 | -78.1% | 0.02% | -76.3% |
| Q3 2018 | $1,456,000 | +1133.9% | 13,400 | +620.8% | 0.08% | +216.7% |
| Q2 2013 | $118,000 | – | 1,859 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |